Top news of the week: 27.09.2022.
Health Tech startups are booming. These 11 VC investors are behind some of the hottest deals
These investors think big–and invest even bigger.
Prime Medicine becomes the next high-profile biotech to test the IPO waters
The startup, which launched last year with $315 million in funding and plans to advance a new form of gene editing, is one of the first big venture-backed biotechs in several months to seek ...
In The Fed’s Inflation Fight, Biotech May Be The First Casualty
Serious thought should be given to the effect the anticipated Federal Reserve 0.75% rate hike will have on the biotechnology industry and consequently on the health of the nation.
Perlara CEO Ethan Perlstein on reviving a biotech and building the ‘Y Combinator of rare diseases’
The CEO resuscitated the sector’s first “public benefit corporation” during the pandemic, building an unusually transparent model for biotechs. Now, he’s spun out a startup and is planning ...
Middlesex Community College on cutting edge of biotech
LOWELL — When the rest of the world was shut down or working from home due to the COVID-19 pandemic, Middlesex Community College biotechnology students were laboring away in their newly ...
Endpoints News Announces the 11 Most Promising Biotech Startups of 2022
Endpoints News Announces the 11 Most Promising Biotech Startups of 2022
With the IPO Freeze, Dying SPACs Won't Be Coming Back
Blank check companies are a sign of market peaks. Avoid them and depend on profits to finance your company.
Good Day BIO: USDA nominee calls for 'science-based decison-making'
Ending the week with USDA nominee Alexis Taylor’s hearing at the Senate Ag Committee, BIO’s webinar on the impacts of the new drug price controls—and a deal on prescription drug user fees. ...